Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay. - Wikidata - wikimedia - TriplyDB

Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay.

Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay.

http://www.wikidata.org/entity/Q33834662

about

A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulations Critical review evaluating the pig as a model for human nutritional physiology.Temporal expression of transporters and receptors in a rat primary co-culture blood-brain barrier model.Investigation of the effects of the CFTR potentiator ivacaftor on human P-glycoprotein (ABCB1).On the atomic structure of cocaine in solution.On the positional and orientational order of water and methanol around indole: a study on the microscopic origin of solubility.Comparative atomic-scale hydration of the ceramide and phosphocholine headgroup in solution and bilayer environments Enhanced uptake of gH625 by blood brain barrier compared to liver in vivo: characterization of the mechanism by an in vitro model and implications for delivery

P2860

Q34031018-7A02F29A-8BDB-425B-843F-87ECD35FF2AF Q38833748-F811EE9E-DD7F-4FA2-A88F-EAE32AF0AE9E Q38995116-EBB2014F-F47E-485B-82BA-1314B8B24F03 Q47115214-2E8C0FD4-281F-41EB-8F21-85E9392AC28C Q47616835-1019AA19-1709-486C-B9B5-7432A3278DA3 Q53146769-CEDEF2A0-9E08-4F04-9F65-615F5558608E Q56875875-EE601903-30D4-4B8F-8072-BE6CD774B860 Q58741014-6C3A49F3-025B-429B-BEDA-B367525D2C6C

P2860

Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay.

http://www.wikidata.org/entity/Q33834662

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay.

@ast

Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay.

@en

type

label

Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay.

@ast

Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay.

@en

prefLabel

Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay.

@ast

Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay.

@en

P1433

Q33834662-EC323E34-61E1-4929-8836-FA2A9F026A7C

P1476

Q33834662-11D07D12-ED83-446A-9633-7390BD479188

P2093

Q33834662-1003A7EE-19B6-4A8F-A883-CE11A2FF138F

Q33834662-2225EB5C-65D4-47D7-983B-07B0808DD477

Q33834662-7ABC66BC-D104-4005-BA69-83A97C7D4015

P2860

Q33834662-0B129462-F403-45EB-A7CE-6B188AC0BC7A

Q33834662-136A055E-BCF9-4AC4-A7D0-A4A1893E9694

Q33834662-152A3D40-F7D3-4A9D-87CF-F958CCCE3926

Q33834662-1C6E7857-6E96-4417-B842-BABF7FBA0CB0

Q33834662-2177E137-53F3-4F56-B671-E281D72477C1

Q33834662-2A4B08D6-1129-49CE-AA5F-9721C64300E0

Q33834662-3225FC21-82F4-4086-A482-43ED3F2C8890

Q33834662-33EBA9CA-0A1E-4CB0-A4F7-500037AB50CD

Q33834662-38D5E3D3-1164-44AD-BDA4-8B730CCA0AAD

Q33834662-5194D376-C217-4571-97A6-EBE2EAF2941C

P304

Q33834662-79FC16A3-A19A-4DDB-B29B-21D39FF2F736

P31

Q33834662-39B1C6ED-77C1-4FEE-9728-1DE6FCB60095

P356

Q33834662-7EC1A7BE-49E4-4114-843F-B745DF619EFA

P433

Q33834662-69277097-D13E-4575-9FDA-CD8EA432F1FA

P478

Q33834662-F6CD1499-0114-4A82-A657-93F3D7C7C714

P577

Q33834662-7A44220C-A35B-4B75-900E-275B8D125510

P5875

Q33834662-CD2FB7BA-4AE4-421B-96D6-5C1231724B68

P698

Q33834662-EE91229E-3F45-48BE-B347-65882F92B58A

P921

Q33834662-94B1196C-7AC9-40E3-9191-E30B627B84C9

P932

Q33834662-4B162689-B639-4E5E-82DF-62C9AFC1F3EB

P356

1087057113497981

P1433

Journal of Biomolecular Screening

P1476

Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay.

@en

P2093

Evan D Kharasch

http://www.w3.org/2001/XMLSchema#string

Karen J Regina

http://www.w3.org/2001/XMLSchema#string

Scott D Campbell

http://www.w3.org/2001/XMLSchema#string

P2860

Blood-brain barrier drug targeting: the future of brain drug development.

Cholesterol interactions with phospholipids in membranes.

Coexistence of passive and carrier-mediated processes in drug transport.

Physicochemical selectivity of the BBB microenvironment governing passive diffusion--matching with a porcine brain lipid extract artificial membrane permeability model.

Chemical and enzyme-assisted syntheses of norbuprenorphine-3-β-D-glucuronide.

Membrane organization and lipid rafts.

Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology.

Recent advances in computational prediction of drug absorption and permeability in drug discovery.

Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?

Effect of cholesterol on the structure of a phospholipid bilayer.

P304

437-444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1087057113497981

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255954784

http://www.w3.org/2001/XMLSchema#string

P698

23945876

http://www.w3.org/2001/XMLSchema#string

P921

blood–brain barrier

P932

4078735

http://www.w3.org/2001/XMLSchema#string